Navigation Links
CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
Date:9/11/2009

WOBURN, Mass., Sept. 11 /PRNewswire/ -- The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their 2nd West Coast Forum on Clinical Supply Chain Management. The conference takes place in Burlingame, CA, on October 28-29, 2009.

Chaired by Frank Reale (Worldwide Regulatory Coordination and Clinical Supplies, Merck), discussion throughout the conference promises to be both interactive and informative. Particular attention will be paid to actionable takeaways that can have a near-immediate impact on the efficiency of clinical supply chain operations.

The speaking faculty for the event is second to none. Drawing largely from the West Coast, the conference features 13 industry perspectives from organizations including Merck, Schering-Plough, Elan Pharmaceuticals, Cerexa, Santen, Celgene, Facet Biotech, ImClone Systems, MedImmune, Medivation and Talecris. Attendees will network with peers and learn to:

  • Avoid re-labeling costs and risks by using IVR/IWR technology for IMP expiry date management
  • Save money and reduce waste with increased accuracy in supply forecasting
  • Satisfy clinical supply needs regardless of complex sourcing challenges
  • Prevent delays by avoiding or coping with import/export violations
  • Ensure the successful and timely delivery of clinical supplies to sites around the globe
  • Create contingency plans for natural disasters, lost lots, etc.

The conference is the industry's best opportunity to walk away with the latest insights on clinical supply chain management. For more information on the conference or to view the entire agenda, please visit cbinet.com/supplywest.

About CBI:

A subsidiary of Advanstar Communications, The Center for Business Intelligence is dedicated to developing market-driven, unbiased conferences in the pharmaceutical, biotechnology, and medical device industries. CBI's conferences provide a unique platform for concrete, real-life examples that can be applied to any organization immediately, significantly impacting both costs and revenue. For more information, please visit cbinet.com.

For additional information or media inquiries, please contact: Emily Forest, Marketing Manager, at 339-298-2156.

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE Center for Business Intelligence
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLife Announces First Clinical Use of BioFoam(R)
2. Martek Announces Settlement of Patent Dispute with Capsugel France
3. Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin(R) (MP-376) Treatment in Cystic Fibrosis Patients
4. Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
5. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
6. Misonix Announces New Sales Agency Agreement for Middle East, India and Pakistan
7. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
8. Biovista Inc. Announces Positive Efficacy Results in a Pre-clinical Trial of its BVA-201 Repositioned Drug for Multiple Sclerosis
9. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
10. Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial Win;
11. Medivation Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
(Date:3/23/2017)... -- NetworkNewsWire Editorial Coverage  ... Cancer remains one of the ... care systems, in terms of costs and resources. However, as ... development of innovative and efficient therapies that demonstrate higher chances ... of cancer treatments, a growing number of patients receiving immuno-oncology ...
(Date:3/23/2017)... YORK , March 23, 2017 ... look at four equities in the Biotech industry: Sangamo ... Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics ... 21 st , 2017, Credit Suisse upgraded its rating on ... by downloading their free report at: ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... regeneration from small lab samples to full-size tissues, bones, even whole organs to ... vascular system that delivers blood deep into the developing tissue. , Current ...
Breaking Biology Technology:
(Date:3/16/2017)... -- CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog ... Used combined in one project, multi-biometric solutions provide ... ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today announces that ... uncover insights to support its reporting, help direct future campaigns, and ... youth charity will be using Brandwatch Analytics social listening and analytics ... of the topics and issues that are a priority for its ... "Until recently ...
(Date:3/2/2017)... -- Summary This report provides all the ... its partnering interests and activities since 2010. Download ... Partnering Deals and Alliance since 2010 report provides an ... the world,s leading life sciences companies. On ... inclusion of the most up to date deal and ...
Breaking Biology News(10 mins):